Pathological mechanisms and advances in neoadjuvant PD-1 blockade combined with chemotherapy for head and neck cancer
Abstract In the most recent edition of Holistic Integrative Oncology, a study by Han and colleagues revealed that combining neoadjuvant programmed cell death 1 (PD-1) blockade with chemotherapy is effective for treating locally advanced head and neck squamous cell carcinoma. The retrospective analys...
Saved in:
| Main Authors: | Yun-jing Hou, Xin-xin Yang, Hong-xue Meng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2024-12-01
|
| Series: | Holistic Integrative Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s44178-024-00140-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathological regression patterns following neoadjuvant chemo-immunotherapy in head and neck squamous cell carcinoma: a pilot study
by: Dikan Wang, et al.
Published: (2025-08-01) -
Statin Drugs Are Associated With Response to Immune Checkpoint Blockade in Recurrent/Metastatic Head and Neck Cancer
by: Tyler J. Kristoff, et al.
Published: (2025-03-01) -
Salvage chemotherapy after progression on immunotherapy in recurrent/metastatic squamous cell head and neck carcinoma
by: Sandra Llop, et al.
Published: (2024-11-01) -
Integrated peripheral blood multi-omics profiling identifies immune signatures predictive of neoadjuvant PD-1 blockade efficacy in head and neck squamous cell carcinoma
by: Hao Zhang, et al.
Published: (2025-06-01) -
The association between body mass index and efficacy of pembrolizumab as second‐line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma
by: Xinyi Zhang, et al.
Published: (2023-02-01)